No Detail Found!

Temporal association between antibiotic use and resistance in Gram-negative bacteria

Author(s)
Wael Mansy Department, College of Pharmacy, King Saud University, KSA
Muzaheed Department of Clinical Laboratory Science, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, KSA
Sanjay Rathod Department of Post Graduate Studies and Research in Microbiology, Gulbarga University, Gulbarga, India.
Abstract
Background: The present investigation has attempted to enhance the understanding of the occurrence of interaction at a time between antibiotic usages with resistance ability of antimicrobial pathogens. Methods and materials: The collection of data on prescription and consumption of antibiotics and database on susceptibility covering isolation rate of resistance potential per quarter was collected. Results: The prescription rate of third-generation cephalosporins and Fluoroquinolones has shown an increased annual resistance rate of gramnegative bacterial strains. The results showed a positive significant correlation between two quarterly lagged numbers of BLBLIs that indicated increased susceptibility to the resistance potential of the strains, whereas levofloxacin and meropenem exhibited no association with resistance to the infections. Conclusion: The usage of BLBLIs showed promising results against infections, still, it required a cautious planning and wide understanding of acquiring and sustaining resistance to BLBLIs and its associated antibiotics at the clinical level.
Publication Details
Page(s) 13-18
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Klebsiella pneumoniae, B-Lactam/ B-lactamase inhibitors, ceftazidime, Piperacillin/Tazobactam, Klebsiella pneumoniae
References
Drawz ,Sarah M.,Krisztina M.,Papp-Wallace M.,Bonomo A. .2014 .New β-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrobial agents and chemotherapy, 58(4) : 1835-1846.
Tamma Pranita D.,Jesus Pranita D. .2017 .The use of noncarbapenem β-lactams for the treatment of extended-spectrum β- lactamase infections. Clinical Infectious Diseases, 64(7) : 972-980.
Bol TS,Iida M,Mostafa S M .2019 .Antibiotic Resistance Trend of Uropathogens in a Tertiary Teaching Hospital in Rasht Iran a Longitudinal Study. Int. J. Pharm. Phytopharm. Res, 9(2) : 98-102.
Bradford .2001 .Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical microbiology reviews, 14(4) : 933-951.
Paterson ,Wen-Chien Ko .2004 .Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β- lactamases. Clinical Infectious Diseases, 39(1) : 31-37.
AlOsaimi K.M AlOtaibi F.M,AL-Anazi A,AlMotairi A,Altujjar A.R.,Factors A.R. .2018 .Affecting Physicians' Choice of Antibiotics for Treatment of Community Acquired Urinary Tract Infections and Their Correlation with Antimicrobial Susceptibility Test Results in King Khalid University Hospital during 2013-2014. J. Pharm. Res. Allied. Sci, 7(1) : 19-25.
Stone ,Archana Gupta,Saiman and Lisa .2003 .Attributable costs and length of stay of an extendedspectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit. Infection Control & Hospital Epidemiology, 24(8) : 601-606.
Almazroea AH,Almugheerbi SI,Alamri MA,Alloqmani MM,Almohammadi GA,Bazarbay AA,Khoshhal BA . .Prevalence of Antibiotic Use for Pediatric Acute Viral Gastroenteritis in Medinah Medicine Almunwarah. KSA. Pharmacophores. 2019 Nov, 1(6) : 37-49.
Vardakas Z.,Giannoula S.,Tansarli Petros I. Rafailidis,Falagas Matthew E. .2012 ."Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. " Journal of antimicrobial chemotherapy, 67(12) : 2793-2803.
Paterson ,Robert A.,Bonomo A. .2005 .Extended-spectrum β- lactamases: a clinical update. Clinical microbiology reviews, 18(4) : 657-686.
Ofer-Friedman .2015 .Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. infection control & hospital epidemiology, 36(8) : 981-985.
Drawz ,Sarah M.,Robert A.,Bonomo A. .2010 .Three decades of β-lactamase inhibitors. Clinical microbiology reviews, 23(1) : 160-201.
Piroth ,Jean-Marc Doise .1998 ."Spread of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae: Are β-Lactamase Inhibitors of Therapeutic Value?." Clinical infectious diseases. , 27(1) : 76-80.
Belaaouaj .1994 .Nucleotide sequences of the genes coding for the TEM-like β- lactamases IRT-1 and IRT-2 (formerly called TRI-1. FEMS microbiology letters, 120(1-2) : 75-80.
Wong-Beringer Nancy,Lee David A.,Pegues Karen,Bush Karen .2002 .Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clinical Infectious Diseases, 34(2) : 135-146.
.2017 .WHO Collaborating Centre for Drug Statistics Methodology.Structure and principles. _principles. Accessed 2 Aug, : .
Goossens .2005 .Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet, 365(9459) : 579-587.
Goossens H .2009 .Antibiotic consumption and link to resistance. Clin Microbiol Infect, 15 : 12-5.
Hsu ,Li-Yang ,Thean-Yen Tan,Vincent H. Tam Tan,Tse-Hsien Koh Tan .2010 .Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrobial agents and chemotherapy, 54(3) : 1173-1178.
Gilca Marie,Gourdeau Marie .2012 .Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada. Antimicrobial agents and chemotherapy, 56(2) : 639-646.
Cowpertwait PSP,Metcalfe AV .2009 .Introductory time series with R. , : .
Box GEP,Jenkins GM,Reinsel GC .1996 .Box-Jenkins modelling in medical research. Stat Methods Med Res, 5 : 3-22.
Hyndman RJ,Athanasopoulos G .2014 .Forecasting; principles and practice. , : .
Harris ,Patrick NA,Mo Yin,Tambyah Paul A. .2015 .Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae. Antimicrobial resistance and infection control, 4(1) : 14.
Ng ,Wendy X.,Khong Paul A.,Tambyah David C.,Lye David C. .2016 .Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. PLoS One, 11(4) : .
Tamma Pranita D.,Jesus Pranita D. .2017 .The use of noncarbapenem β-lactams for the treatment of extended-spectrum β- lactamase infections. Clinical Infectious Diseases, 64(7) : 972-980.
Sun Ramanan,Laxminarayan Ramanan .2012 .Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clinical infectious diseases, 55(5) : 687-694.
Liu X,Thungrat K,Boothe DM .2016 .Occurrence of OXA-48 carbapenemase and other β-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States,. , 7 : e1057.
Lai ,Wang ,Chen-Chen Chu,Che-Kim Tan,Ching-Lan Lu,Yi-Chieh Lee,Yu-Tsung Huang,Ping-Ing Lee,Hsueh PoRen .2011 .Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. , 66(6) : 1374-1382.
Jacoby T. S.,Kuchenbecker R. S.,Dos Santos R. P.,Magedanz L.,Guzatto P.,Moreira L. B. .2010 .Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. Journal of Hospital Infection, 75(1) : 23-27.
Wang ,Jacoby David C.,Hooper David C. .2004 .Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrobial agents and chemotherapy, 48(4) : 1295-1299.
0

Citations

0

Downloads

13

Views